Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass Spectrometry
Clinical Pharmacology & Therapeutics · 2024
DOI: 10.1002/cpt.3066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Shigehiro Koganemaru und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan. Hauptthemen laut MEDLINE: Antineoplastic Agents, Frontotemporal Dementia, Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Taiho Pharmaceutical Co., Ltd., Japan Research Foundation for Clinical Pharmacology, Taiho Pharmaceutical.
Abstract (Originalsprache)
Hypoxic regions in solid tumors are highly resistant to drugs and thus represents an obstacle in drug discovery. Currently, however, there are technical barriers in sampling human hypoxic tumors and examining drug delivery with high sensitivity and accuracy. Herein, we present a new platform combining functional endoscopy and highly sensitive liquid chromatography‐mass spectrometry (LC–MS) to assess drug delivery to hypoxic regions. Because oxygen saturation endoscopic imaging (OXEI), a functional endoscopy, can evaluate lesions and hypoxia in real‐time by simultaneously acquiring a pseudocolor map of oxygen saturation and conventional endoscopic images, this platform can be used to evaluate drug delivery with human samples from hypoxic regions. As the first clinical application of this platform, the relationship between hypoxic regions and the concentration of trifluridine (FTD) incorporated into DNA was evaluated in patients with advanced gastric cancer treated with FTD/tipiracil (FTD/TPI; n = 13) by obtaining and analysis of tissue samples by OXEI and LC–MS and vascular maturity index by CD31/α‐SMA staining ex vivo . The results showed that the concentration of FTD was significantly higher in the normoxic region than in the hypoxic region ( P < 0.05) and there were significantly more immature vessels in hypoxic regions than in normoxic regions ( P < 0.05). These results indicate that the platform was sufficiently sensitive to evaluate differences in drug anabolism in different oxygenic regions of human tumor tissue. This new platform allows quantitative drug analysis in hypoxic regions and is expected to initiate a new era of drug discovery and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
- Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
- Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.
- Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
ORCID-Profile: Shigehiro Koganemaru
Förderung
- Taiho Pharmaceutical Co., Ltd.
- Japan Research Foundation for Clinical Pharmacology
- Taiho Pharmaceutical
Zitieren
APA
Koganemaru, S., Fuchigami, H., Yamashita, H., Morizono, C., Sunakawa, H., Kawazoe, A., Nakamura, Y., Kuboki, Y., Shitara, K., Yano, T., Doi, T., & Yasunaga, M. (2024). Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass Spectrometry. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3066
Vancouver
Koganemaru S, Fuchigami H, Yamashita H, Morizono C, Sunakawa H, Kawazoe A, et al. Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass Spectrometry. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3066
BibTeX
@article{Koganemaru2024,
author = {Koganemaru, Shigehiro and Fuchigami, Hirobumi and Yamashita, Hiroki and Morizono, Chihiro and Sunakawa, Hironori and Kawazoe, Akihito and Nakamura, Yoshiaki and Kuboki, Yasutoshi and Shitara, Kohei and Yano, Tomonori and Doi, Toshihiko and Yasunaga, Masahiro},
title = {Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass Spectrometry},
journal = {Clinical Pharmacology & Therapeutics},
year = {2024},
doi = {10.1002/cpt.3066}
}
EUVIMED